Image
|
Figure Caption
Fig. 11 Molecular docking diagram of the ten targets and the main components. (A) AKT1/quercetin-3-O-sambubioside. (B) EGFR/1-Hydroxy-2-methoxy-3-methyl-anthraquinone. (C) HRAS/quercetin-3-O-sambubioside. (D) IL2/1-Hydroxy-2-methoxy-3-methyl-anthraquinone. (E) IL6/quercetin-3-O-sambubioside. (F) MAPK3/1-Hydroxy-2-methoxy-3-methyl-anthraquinone. (G) NFKB1/Z-6-O-p-feruloyl scandoside methyl ester.(H) PIK3R1/quercetin-3-O-sambubioside. (I) RELA/ E-6-O-p-feruloyl scandoside methyl ester. (J) SRC/quercetin-3-O-[2-O-(6-O-E-sinapoyl)-β-D-glucopyranosyl]-β-D-galactopyranoside.
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and
ZFIN has permission only to display this image to its users.
Additional permissions should be obtained from the applicable author or publisher of the image.
Full text @ Drug Des Devel Ther